| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.06. | Sona Nanotech Inc: Sona Nanotech appoints Fleming director | 1 | Stockwatch | ||
| 11.06. | Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors | 1 | CNW | ||
| 05.05. | Sona Nanotech Announces Clinical Strategy With Two THT Combination Therapy Studies In Melanoma | 4 | CNW | ||
| 27.04. | Sona Nanotech Showcases Cancer Therapy Results At Prestigious Industry Cancer Conferences | 1 | CNW | ||
| 16.04. | Sona Nanotech Inc: Sona Nanotech appoints Smylie, Trites to advisory board | 1 | Stockwatch | ||
| 16.04. | Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific Advisory Board | 1 | CNW | ||
| 13.04. | Sona Nanotech Inc: Sona Nanotech upbeat about THT's effect on tumours | 2 | Stockwatch | ||
| 13.04. | Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies | 2 | CNW | ||
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 08.04. | Sona Nanotech Inc: Sona says THT shows strong combo cancer efficacy | 3 | Stockwatch | ||
| 07.04. | Sona Nanotech's THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination with Immunotherapy In Peer-reviewed Preclinical Study | 1 | CNW | ||
| 17.03. | Sona Nanotech Inc: Sona Nanotech to hold investor webinar March 18 | 3 | Stockwatch | ||
| 16.03. | Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study | 1 | CNW | ||
| 20.10.25 | Sona Nanotech Inc.: Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study | 717 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 20, 2025) - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce the completion of its first-in-human clinical... ► Artikel lesen | |
| 17.10.25 | Sona Nanotech Inc.: Sona Nanotech To Host Investor Webinar To Discuss Clinical Study | 1.233 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that it will host a webinar on Monday, October 20th at noon... ► Artikel lesen | |
| 25.08.25 | Sona Nanotech Inc.: Sona Provides Update on First-In-Human Clinical Trial | 1.007 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - August 25, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 23.07.25 | Sona Nanotech Inc.: Sona Announces Canadian Melanoma Clinical 'Pilot' Study Ethics Approval | 926 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 23, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 19,000 | +2,59 % | BioNTech, Merck oder Formycon? Das ist unser Geheimtipp! | Die Aktien von BioNTech, Merck und Formycon präsentieren sich derzeit mit einer unterschiedlichen Kursdynamik. Während BioNTech nach einer Erholungsbewegung wieder verstärkt in den Fokus wachstumsorientierter... ► Artikel lesen | |
| OBDUCAT | 0,048 | -4,00 % | NGM MARKET NOTICE: #26-16 Information regarding the last day of trading in paid subscribed units and the first day of trading in warrants issued by Obducat AB | ||
| SOLESENCE | 0,680 | -2,86 % | Solésence, Inc.: Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results | Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty... ► Artikel lesen | |
| ONTO INNOVATION | 286,20 | +12,28 % | $1000 Invested In Onto Innovation 5 Years Ago Would Be Worth This Much Today | ||
| RIBER | 10,440 | +7,63 % | RIBER receives a new order from 3SP Technologies for a production platform | RIBER receives a new order from 3SP Technologies for a production platform Bezons (France), July 9, 2026 - 8:00 am (CET) - RIBER, a global market leader in molecular beam epitaxy (MBE) equipment for... ► Artikel lesen | |
| KOPIN | 3,390 | -1,54 % | Fabric.AI (Nasdaq: FABC) Stockholders Ratify Kopin Strategic Partnership to Develop Neural I/o MicroLED Optical Interconnect Technology for Next Generation AI Data Centers | NEW YORK, NY, June 24, 2026 (GLOBE NEWSWIRE) -- Fabric.AI, Inc. (Nasdaq: FABC) ("Fabric.AI" or the "Company"), a fabless semiconductor company developing MicroLED-based optical interconnects for AI... ► Artikel lesen | |
| GAUZY | 0,420 | -2,39 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F | TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on May 19, 2026... ► Artikel lesen | |
| NVE | 80,50 | +0,62 % | Dividendenbekanntmachungen (18.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2A SPA IT0001233417 - 0,104 EUR AIR LIQUIDE SA FR0000120073 - 3,7 EUR ALCOA CORPORATION CDIS AU0000339426 0,1 USD 0,086 EUR ALLISON... ► Artikel lesen | |
| NANOFORM FINLAND | 0,759 | +1,61 % | Nanoform Finland Oyj: Nanoform Q1 2026 report - Record first quarter revenue, income and gross margin, first exclusivity deal signed around our Biologics technology | Nanoform Finland Plc | Company Release | May 19, 2026 at 08:10:00 EEST
Record first quarter revenue, income and gross margin. Revenue grew by 45%, gross margin reached 94% and operating costs fell by... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,189 | +1,07 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 09.06.2026 | Das Instrument G85 CA35958L1013 FUERTE METALS CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 09.06.2026 und ex Kapitalmassnahme am 10.06.2026 The instrument G85 CA35958L1013 FUERTE METALS CORP.... ► Artikel lesen | |
| DOTZ NANO | 0,015 | +0,67 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| VEECO INSTRUMENTS | 52,02 | +9,89 % | Veeco Instruments Inc.: Veeco Announces $250 Million+ in Equipment Orders for Manufacturing Indium Phosphide Lasers | High-volume orders from multiple customers for its Spector, Lumina and Wet Processing Systems to drive strong growth. PLAINVIEW, N.Y., May 05, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ:... ► Artikel lesen | |
| LAMPETIA | 0,140 | 0,00 % | EQS-Adhoc: Lampetia AG: Lampetia hebt Gewinnprognose für das laufende Geschäftsjahr deutlich an | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Prognose / Gesamtjahr
Lampetia AG hebt Gewinnprognose für das laufende Geschäftsjahr deutlich an
01.07.2026 / 19:30 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| NANOVIRICIDES | 1,380 | +2,22 % | Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily | SHELTON, CT / ACCESS Newswire / July 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, reports that a... ► Artikel lesen | |
| ACACIA RESEARCH | 3,820 | +0,53 % | ACACIA RESEARCH CORP - 8-K, Current Report |